ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
Growth Shares
My top 5 ASX growth shares to buy right now
Growth Shares
10 top ASX shares to buy when the bear market ends
⏸️ Investing
3 ASX 200 shares in my Easter buy basket
Growth Shares
Where to invest $10,000 in ASX 200 shares right now
Coronavirus News
3 of the best ASX 200 healthcare shares to buy right now
Share Market News
3 ASX 200 healthcare shares surging higher today
How to invest
How to turn $20,000 into $600,000 with ASX 200 shares in 10 years
Coronavirus News
How the ResMed share price could get a boost from the White House
How to invest
Where to invest $1,000 into ASX shares in April
Share Market News
Top brokers name 3 ASX 200 shares to sell next week
Healthcare Shares
2 ASX shares helping the fight against coronavirus
Share Gainers
Why Afterpay, Breville, Catapult, & ResMed shares are storming higher
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.
